使用生物心理社会精神视角的癌症相关症状框架:一个范围审查
Megan Miller1, Eric Vachon2, Kristine Kwekkeboom1
1School of Nursing, University of Wisconsin-Madison, Madison, WI, USA.
Western journal of nursing research
|September 4, 2023
概括
一项审查确定了癌症症状研究的11个框架. 只有四个完全集成的生物心理社会精神层面,突出了在癌症症状管理中需要整体方法的需要.
科学领域:
- 瘤学 护理 护理专业
- 症状科学 症状科学
- 整合性健康 整合性健康
背景情况:
- 了解和管理癌症相关症状的进展正在进行中.
- 对于有效的症状管理,全面的生物心理社会精神视角至关重要.
- 现有的研究框架需要评估,以使其与症状的整体观点保持一致.
研究的目的:
- 对现有的适用于癌症相关症状研究的框架进行范围审查.
- 探索和描述已识别的框架.
- 通过生物心理社会精神的镜头来评估这些框架.
主要方法:
- 使用了一个范围审查方法.
- 确定了指导癌症症状研究的框架.
- 每个框架都被评估为其生物心理社会精神元素的整合.
主要成果:
- 确定了11个框架,用于指导癌症症状研究.
- 所有框架都是在美国开发的,由护士科学家领导.
- 虽然所有框架都涉及生物心理社会方面,但只有四个框架明确包括精神.
结论:
- 四个框架为推进癌症症状研究和整体实践提供了坚实的基础.
- 需要进一步开发和修改框架,以充分纳入癌症症状的精神层面.
- 这一回顾为采用强调症状经验的精神方面框架提供了基础.
相关概念视频
Dimensions of Health and Illness
7.4K
The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
7.4K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


